https://www.ispor.org/vih-articles/Volume-18--Issue-3/Ibrutinib-for-the-treatment-of-Mantle-Cell-Lymphoma-(MCL)--evaluating-the-correlation-between-patient-reported-outcomes-and-durability-of-response-in-a-Phase-2-study
Ibrutinib for the treatment of Mantle Cell Lymphoma (MCL)- evaluating the correlation between...
mantle cell lymphoma mclfor the